Stocks and Investing Stocks and Investing
Fri, January 20, 2023
Thu, January 19, 2023

Colin Rusch Maintained (TDOC) at Buy with Decreased Target to $37 on, Jan 19th, 2023


Published on 2024-10-28 01:00:11 - WOPRAI, Colin Rusch
  Print publication without navigation


Colin Rusch of Oppenheimer, Maintained "Teladoc Health, Inc." (TDOC) at Buy with Decreased Target from $45 to $37 on, Jan 19th, 2023.

Colin has made no other calls on TDOC in the last 4 months.



There are 9 other peers that have a rating on TDOC. Out of the 9 peers that are also analyzing TDOC, 7 agree with Colin's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Marc Solecitto of "Barclays" Maintained at Hold with Decreased Target to $28 on, Wednesday, January 18th, 2023
  • Daniel Grosslight of "Citigroup" Maintained at Hold with Decreased Target to $33 on, Tuesday, December 13th, 2022
  • Jonathan Yong of "Credit Suisse" Maintained at Hold with Decreased Target to $30 on, Monday, October 31st, 2022
  • Steve Valiquette of "Barclays" Maintained at Hold with Decreased Target to $32 on, Thursday, October 27th, 2022
  • Sandy Draper of "Guggenheim" Upgraded from Strong Sell to Hold on, Monday, October 24th, 2022
  • Jailendra Singh of "Truist Securities" Maintained at Hold with Decreased Target to $29 on, Friday, October 21st, 2022
  • George Hill of "Deutsche Bank" Maintained at Hold with Decreased Target to $31 on, Tuesday, September 27th, 2022


These are the ratings of the 2 analyists that currently disagree with Colin


  • Robert Simmons of "DA Davidson" Maintained at Strong Buy with Decreased Target to $40 on, Tuesday, October 25th, 2022
  • Sean Dodge of "RBC Capital" Maintained at Buy with Decreased Target to $35 on, Wednesday, September 28th, 2022

Contributing Sources